NO992099L - Ekstraksjonsmetode - Google Patents

Ekstraksjonsmetode

Info

Publication number
NO992099L
NO992099L NO992099A NO992099A NO992099L NO 992099 L NO992099 L NO 992099L NO 992099 A NO992099 A NO 992099A NO 992099 A NO992099 A NO 992099A NO 992099 L NO992099 L NO 992099L
Authority
NO
Norway
Prior art keywords
extraction
disaggregating
homogenised
dissociating
mammals
Prior art date
Application number
NO992099A
Other languages
English (en)
Other versions
NO992099D0 (no
NO326302B1 (no
Inventor
Jostein Holtlund
Siri Dale
Magne K Fagerhol
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26310325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO992099(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9622839A external-priority patent/GB9622839D0/en
Priority claimed from GB9707148A external-priority patent/GB9707148D0/en
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of NO992099D0 publication Critical patent/NO992099D0/no
Publication of NO992099L publication Critical patent/NO992099L/no
Publication of NO326302B1 publication Critical patent/NO326302B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805—Haemoglobins; Myoglobins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Extraction Or Liquid Replacement (AREA)
NO19992099A 1996-11-01 1999-04-30 Metode for a ekstrahere proteiner NO326302B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9622839A GB9622839D0 (en) 1996-11-01 1996-11-01 Process
GB9707148A GB9707148D0 (en) 1997-04-08 1997-04-08 Process
PCT/GB1997/003013 WO1998020355A1 (en) 1996-11-01 1997-11-03 Process for the extraction of proteins

Publications (3)

Publication Number Publication Date
NO992099D0 NO992099D0 (no) 1999-04-30
NO992099L true NO992099L (no) 1999-04-30
NO326302B1 NO326302B1 (no) 2008-11-03

Family

ID=26310325

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992099A NO326302B1 (no) 1996-11-01 1999-04-30 Metode for a ekstrahere proteiner

Country Status (12)

Country Link
US (1) US6225072B1 (no)
EP (1) EP0937259B1 (no)
JP (1) JP4105768B2 (no)
AT (1) ATE278964T1 (no)
AU (1) AU4790597A (no)
CA (1) CA2268926A1 (no)
DE (1) DE69731103T2 (no)
DK (1) DK0937259T3 (no)
ES (1) ES2225956T3 (no)
NO (1) NO326302B1 (no)
PT (1) PT937259E (no)
WO (1) WO1998020355A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0229747D0 (en) 2002-12-20 2003-01-29 Axis Shield Asa Assay
WO2009065551A1 (en) * 2007-11-20 2009-05-28 Roche Diagnostics Gmbh Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
EP2352762A1 (en) * 2008-11-03 2011-08-10 Schering Corporation Inflammatory bowel disease biomarkers and related methods of treatment
EP2202320A1 (en) 2008-12-24 2010-06-30 Agendia B.V. Methods and means for typing a sample comprising colorectal cancer cells
US20130164776A1 (en) 2009-11-23 2013-06-27 Lars Olof A Hansson Method used in a human or animal faeces sample processing system, and a sample processing system
NO336551B1 (no) 2011-06-21 2015-09-28 Magne Fagerhol Forbedret ELISA for kalprotektin i fekalprøve eller gastrointestinaltraktsprøve
NO20110895A1 (no) 2011-06-21 2012-12-24 Magne Fagerhol Kompetitive S100A9 immunoanalyser
WO2013132347A2 (en) 2012-03-06 2013-09-12 Calpro As Improved elisa immunoassay for calprotectin
WO2013132338A2 (en) 2012-03-06 2013-09-12 Calpro As Competitive immunoassay for calprotectin
DK2947459T3 (en) 2014-05-21 2017-10-23 Bühlmann Laboratories Ag Method for Determining a Protein
MX2018003376A (es) 2015-09-17 2018-08-15 Amgen Inc Prediccion de la respuesta clinica a antagonistas de il23 mediante el uso de biomarcadores de la via de il23.
WO2017112536A1 (en) 2015-12-22 2017-06-29 Amgen Inc. Ccl20 as a predictor of clinical response to il23-antagonists
CN111936059B (zh) * 2018-03-27 2024-09-06 精密科学公司 稳定血红蛋白的方法和实施该方法的试剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8318754D0 (en) 1983-07-11 1983-08-10 Fagerhol M K F Human proteins anti-sera test kits
EP0281251A3 (en) * 1987-02-04 1988-09-28 International Immunoassay Laboratories, Inc. A method for preparing a fecal sample composition for immunoassay testing
US5139934A (en) * 1990-05-25 1992-08-18 Becton, Dickinson And Company Substrate composition and method for solid phase urease immunoassay
US5455160A (en) * 1993-05-27 1995-10-03 Fagerhol; Magne K. Diagnostic test and kit for disease or disorders in the digestive system

Also Published As

Publication number Publication date
JP2001503863A (ja) 2001-03-21
NO992099D0 (no) 1999-04-30
NO326302B1 (no) 2008-11-03
DE69731103T2 (de) 2005-11-17
ATE278964T1 (de) 2004-10-15
CA2268926A1 (en) 1998-05-14
PT937259E (pt) 2005-01-31
WO1998020355A1 (en) 1998-05-14
US6225072B1 (en) 2001-05-01
ES2225956T3 (es) 2005-03-16
DE69731103D1 (de) 2004-11-11
DK0937259T3 (da) 2005-01-31
EP0937259A1 (en) 1999-08-25
EP0937259B1 (en) 2004-10-06
AU4790597A (en) 1998-05-29
JP4105768B2 (ja) 2008-06-25

Similar Documents

Publication Publication Date Title
NO992099D0 (no) Ekstraksjonsmetode
WO1999042839A3 (en) Treating cancer
DE69533159D1 (de) Miniaturisierte probenvorbereitungsvorrichtungen sowie systeme zur feststellung und behandlung von analyten
CA2143999A1 (en) Device and method for combined bioaffinity assay and electrophoretic separation
CA2263888A1 (en) Methods and compositions for the detection of cervical cancer
GR3026730T3 (en) Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction
AU5794498A (en) Releasable nonvolatile mass-label molecules
ATE218708T1 (de) Elektrochemischer affinitätsassay
CA2206760A1 (en) Reagent preparation containing magnetic particles in tablet form
WO2000020846A8 (en) Method for imaging tissue
CA2133560A1 (en) Hair analysis method
NO994315L (no) Anordning for prövetaking og testing av fluidpröver
WO1997029199A3 (en) Prostate specific antigen peptides and uses thereof
WO2001057537A3 (en) Methods for diagnosis of alzheimer's disease
EP1767629A3 (en) Methods for the detection, analysis and isolation of nascent proteins
ATE397215T1 (de) Entstörung von immunoassays durch substanzen, die aus den framework-regionen von antikörpern abgeleitet sind
EP1652918A3 (en) Methods for detecting protein interactions using conformationally constrained peptides
DE69924728D1 (de) Nicht-embryonale ependymale neuronale stammzellen und methoden zu ihrer isolierung
IL117201A (en) Process for quantitative detection of analytes and ferrimagnetic and ferromagnetic compounds for use therein
NO994705L (no) Preparering av blodpröver for deteksjon av homocystein og/eller folat
CA2275853A1 (en) Computer directed identification of paraproteins
AU8540098A (en) Device for taking and examining samples
DE69533485D1 (de) Neue polypeptide
EP0404590A3 (en) Method of and reagent for the prevention of turbidity
CA2004068A1 (en) Hair analysis method

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees